P3.09 The effect of combining activin receptor type IIB inhibition and prednisolone treatment in mdx mice von Lachey, J.L, Wong, V, Seehra, J

Volltext

EM.P.1.02 Long-term activin receptor type IIB inhibition improves strength and function of dystrophic muscle von Lachey, J.L, Bogdanovich, S, Pistilli, E.E, Pullen, A.E, Seehra, J

Volltext

G.P.8.06 Treatment with a soluble Activin type llB receptor increases muscle size and strength of dystrophin deficient muscle von Lachey, J.L, Pistilli, E.E, Bogdanovich, S, Pullen, A.E, Pearsall, R.S, Khurana, T.S, Seehra, J

Volltext

M.P.1.03 Preliminary results from single subcutaneous administration of ACE-031, a form of the soluble activin type IIB receptor, in healthy postmenopausal volunteers von Borgstein, N.G, Condon, C.H, Yang, Y, Wilson, D.M, Haltom, E, Lachey, J.L, Seehra, J, Sherman, M.L

Volltext